Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 6/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.35 |
| ▸ | PDE2A | O00408 | 1/20 | 0.35 |
| ▸ | TLR2 | O60603 | 1/20 | 0.34 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.33 |
| ▸ | FEN1 | P39748 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119221 | 0.99 | CACNA1B (0.41) | CACNA1BNR1I2MCL1SCN9APDE2A | |
| SCHEMBL5077281 | 0.98 | CACNA1B (0.41) | CACNA1BNR1I2MCL1SCN9APDE2A | |
| Bromoxynil SCHEMBL18489656 | 0.86 | CACNA1B (0.38) | CACNA1BNR1I2MCL1NR3C1 | |
| SCHEMBL19391755 | 0.86 | CACNA1B (0.38) | CACNA1BNR1I2MCL1SCN9APDE2A | |
| SCHEMBL1965010 | 0.85 | CACNA1B (0.38) | CACNA1BNR1I2PDE2A | |
| SCHEMBL22443243 | 0.85 | CACNA1B (0.39) | CACNA1BNR1I2MCL1SCN9APDE2A | |
| 3,6 Dichloromethoxybenzoic Acid SCHEMBL17927051 | 0.85 | KDM4E (0.40) | CACNA1BNR1I2MCL1ALDH1A1KDM4E | |
| Glyphosate SCHEMBL20723895 | 0.84 | PTGDR2 (0.33) | CACNA1BNR1I2MCL1SCN9ANR3C1 | |
| SCHEMBL677603 | 0.83 | SPR (0.38) | ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL27934056 | 0.83 | AR (0.36) | ALDH1A1NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8076268-B2 | Liquid formulations containing dialkyl sulfosuccinate and hydroxyphenylpyruvate dioxygenase inhibitors | BAYER CROPSCIENCE AG (DE) | 2011-12-13 | — | — | US | disclosed |
| US-20080305953-A1 | Liquid Formulations Containing Dialkyl Sulfosuccinate And Hydroxyphenylpyruvate Dioxygenase Inhibitors | BAYER CROPSCIENCE AG (DE) | 2008-12-11 | — | — | US | disclosed |
| CN-101316507-A | Liquid formulations containing dialkyl sulfosuccinate and hydroxyphenylpyruvate dioxygenase inhibitors | BAYER CROPSCIENCE AG (DE) | 2008-12-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305953-A1 | Liquid Formulations Containing Dialkyl Sulfosuccinate And Hydroxyphenylpyruvate Dioxygenase Inhibitors | HPD, DDT, HAAO | CACNA1B 4687/4885NR1I2 3505/4885MCL1 3906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.